A Phase 4 interventional study of STRATAFIX PDS and Monocryl suture in Wound Closure, Brain Tumor Adult and Spine, sponsored by University of Michigan. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-05.
Sponsored by University of Michigan · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 76 studies in Hemorrhagic Stroke with a site in United States — 22 open to participants now, 28 under way, 1 of them phase 3. Hemorrhagic Stroke · United States.
Among the 76 studies in Hemorrhagic Stroke with a site in United States, this one is the 13th largest by planned enrollment of the 57 interventional ones that give a count, is one of 7 that started in 2025, is one of 2 in phase 4, reaches primary completion later than 4 of the 27 other live ones, and was the 72nd registered.
234 studies on the registry are indexed under Hemorrhagic Stroke; 94 are open to participants now.
Browse Hemorrhagic Stroke studies →22 of the 76 studies in Hemorrhagic Stroke with a site in United States are open now. Recruiting first, the newest first:
Magnetic Tides · Sites in United States
Ages 18–80
University of Minnesota · Sites in United States
Ages 18+
phenox Inc. · Sites in United States
Ages 18+
Johns Hopkins University · Sites in United States
Ages 18+
Joyce Chen · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 62 Hemorrhagic Stroke studies recruiting now, 36 (58%) set no upper age limit and 7 (11%) stop at 75 or younger; 5 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
76 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 8 · Phase 3 3 · Phase 4 2
First in 2003; this study’s year is marked. 7 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 160 is above the median of 58 across 156 interventional studies indexed under Hemorrhagic Stroke.
Median enrollment 30 across the 57 interventional studies, 300 across the 19 observational. Of the 45 that completed or were terminated, 17 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 76 have an industry lead sponsor. The 10 most frequent:
University of Michigan is the lead sponsor of 1,509 studies on the registry; 194 are open to participants now.
Of its 170 completed or terminated interventional studies of FDA-regulated products, 134 (79%) have results posted.
University of Michigan has 1 study filed under Hemorrhagic Stroke — fewer than ten, so there is no comparison to draw.
11 of the studies in Hemorrhagic Stroke with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07649135University of MinnesotaFeasibility of a Remotely Delivered Step Count Intervention in Chronic Stroke | 2026-11-30 |
| NCT05085210Beth Israel Deaconess Medical CenterImproving Visual Field Deficits With Noninvasive Brain Stimulation | 2026-12 |
| NCT04534556Baylor Research InstituteWireless Nerve Stimulation Device To Enhance Recovery After Stroke | 2027-01-01 |
| NCT07053917Johns Hopkins UniversityPsychedelic Healing: Adjunct Therapy Harnessing Opened Malleability | 2027-02 |
| NCT07631078Magnetic TideskTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) Pilot | 2027-02-28 |
Add all 11 to your calendar (.ics) → With an account.
Among the 76 studies in Hemorrhagic Stroke with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This research is studying a device already approved by the Food and Drug Administration (FDA) to treat wound closures. Researchers are studying a large group of people to continue to learn information about the safety of the STRATAFIX suture and how people's bodies react to using it over a long period of time. This research will provide additional information about using STRATAFIX sutures to close surgical wounds.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All participants enrolled will have their scheduled surgery as planned with their wound closed using STRATAFIX.
Device: STRATAFIX PDS and Monocryl suture
STRATAFIX, suture employs a novel incorporation of barbed components to suture resulting in tension holding closure with long-lasting absorbable suture.
Wound complications Bates-Jensen Wound Assessment Tool (BWAT) score
The BWAT evaluates 13 categories including size, depth, edges, undermining, necrotic tissue type and amount, exudate type and amount, skin color, peripheral tissue, granulation tissue and epithelialization with a total score of 65. Minimal severity scores are 10-20 out of the total of 65 with good interrater reliability and validation in a variety of clinical environments. Wounds with scores \<10 will be considered healed.
Time frame: 1 month
Wound complications Bates-Jensen Wound Assessment Tool (BWAT) score
The BWAT evaluates 13 categories including size, depth, edges, undermining, necrotic tissue type and amount, exudate type and amount, skin color, peripheral tissue, granulation tissue and epithelialization with a total score of 65. Minimal severity scores are 10-20 out of the total of 65 with good interrater reliability and validation in a variety of clinical environments. Wounds with scores \<10 will be considered healed. Scores will be separated into specific patient subgroups (e.g., spine procedures vs. cranial procedures, younger vs. older patients)
Time frame: 3 and 6 months
The Wound-Quality of Life (QOL) questionnaire score
This is a 17-point scale with 5 choices each ranging from 17-85. Higher scores indicate worse quality of life.
Time frame: 1, 3 and 6 months
Intraoperative time required for wound closure
Time for intraoperative wound closure will be monitored. Wound closure technique will be video recorded.
Time frame: Immediately following surgery
Percent of participants positive for superficial surgical site infection (SSI)
Assessed using a culture or polymerase chain reaction
Time frame: Up to six months
Number of case deviations and descriptions from prescribed suturing paradigm
A quantification and description for additional suture material required for surgical procedures will be monitored.
Time frame: Immediately following surgery
Liker scale of patient satisfaction with wound
10 point subjective scale indicating patient satisfaction with wound
Time frame: 1, 3 and 6 months
Wound imaging at perioperative followup
Wound pictures during followup period.
Time frame: 1, 3 and 6 months
Wound revision strategy
Description of any wound revision strategies and timing
Time frame: up to 6 months
Plan to share: Undecided — Unclear if manuscript will be published in an ICMJE journal and data from this study are restricted from the University of Michigan Data Use Committee
No publications or documents are linked to this record.
Started Nov 2025 (actual). Primary completion is estimated for Jun 2026, 7 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.